Lots of venture news this week, with more than the usual number of software and Web companies making appearances.
—Flexion Therapeutics raised $33 million in a Series A round led by Versant Ventures and joined by 5AM Ventures and Sofinnova Partners. The Woburn, MA-based startup believes it can cut the shepherd drugs from early development into clinical trials in half the time it normally takes and for as little as $3 million to $5 million, compared to the usual $15 million to $40 million.
—Newton, MA-based Jackpot Rewards raised just over $12 million in the form of convertible debt. The startup, which runs cash-back rewards programs and sweepstakes for online shoppers, has previously raised at least $16 million in equity financing.
—Marketing-technology firm HubSpot of Cambridge, MA, raised a $16 million in a Series C financing round. New investor Scale Ventures led the deal and existing investors General Catalyst Partners and Matrix Partners participated as well.
—Augmenix, a medical-device startup in Waltham, MA, closed a $6.1 million Series B financing round led by Ascension Health Ventures and joined by Versant Ventures, Pinnacle Ventures, Catalyst Health Ventures, and private investors.
—Currensee, an operator of an online community for foreign currency traders, closed its $6 million Series A funding round. North Bridge Venture Partners provided the backing for the Boston-based startup.
—Waltham-based drug developer Synageva BioPharma raised $12 million, completing a $45 million round of financing. New investor New Leaf Venture Partners, as well as return investors, participated in the deal.
—Acton, MA-based optical-switch developer Mintera raised $4.1 million of a potential $5 million round of equity and options financing, according to an SEC filing.
—Illume Software of Concord, MA, added $1 million to its Series A round of financing, which previously totaled $2.4 million. Illume is developing an application to prevent drivers from texting or chatting on cell phones while they’re operating their cars.
—New Haven, CT- and Seattle-based Revolution Computing raised $9 million from North Bridge Venture Partners and Intel Capital. Revolution provides software and support for the statistical programming language known as “R.”
—STR Holdings of Enfield, CT, set the terms of its proposed IPO: 12.3 million shares of common stock at a price of $13 to $15. STR makes sheets and film to encapsulate solar cells.
—Genomic test maker Nuclea Biotechnologies of Pittsfield, MA, raised $3.4 million in new equity financing, according to a regulatory filing. Nuclea has collaborations with the Dana-Farber Cancer Institute in Boston and the Johns Hopkins School of Medicine in Baltimore.
